KALA BIO, INC. Related Party Transaction, Due from (to) Related Party, Current
KALA BIO, INC. (KALA) had Related Party Transaction, Due from (to) Related Party, Current of $26.00 thousand as of 2022-12-31, per its 10-Q filed 2023-08-04.
Discontinued › Notes
us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent · last filed 2023-08-04
- 2022-12-31: Related Party Transaction, Due from (to) Related Party, Current $26.00K.
| Period end | Related Party Transaction, Due from (to) Related Party, Current |
|---|---|
| 2022-12-31 | $26.00K 10-Q · filed 2023-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |